AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27
Thalidomide for previously untreated indolent or smoldering multiple myeloma
Authors: Rajkumar, SV Dispenzieri, A Fonseca, R Lacy, MQ Geyer, S Lust, JA Kyle, RA Greipp, PR Gertz, MA Witzig, TE
Citation: Sv. Rajkumar et al., Thalidomide for previously untreated indolent or smoldering multiple myeloma, LEUKEMIA, 15(8), 2001, pp. 1274-1276
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival
Authors: Dispenzieri, A Lacy, MQ Kyle, RA Therneau, TM Larson, DR Rajkumar, SV Fonseca, R Greipp, PR Witzig, TE Lust, JA Gertz, MA
Citation: A. Dispenzieri et al., Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival, J CL ONCOL, 19(14), 2001, pp. 3350-3356
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Therneau, TM Kyle, RA Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation, AM J HEMAT, 68(4), 2001, pp. 269-275
Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis
Authors: Hayman, SR Bailey, RJ Jalal, SM Ahmann, GJ Dispenzieri, A Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Rajkumar, SV Witzig, TE Lust, JA Fonseca, R
Citation: Sr. Hayman et al., Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis, BLOOD, 98(7), 2001, pp. 2266-2268
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death
Authors: Steensma, DP Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Lust, JA Offord, JR Plevak, MF Therneau, TM Witzig, TE
Citation: Dp. Steensma et al., A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death, BLOOD, 97(8), 2001, pp. 2522-2523
Prognostic value of bone marrow angiogenesis in multiple myeloma
Authors: Rajkumar, SV Leong, T Roche, PC Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Kyle, RA Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Prognostic value of bone marrow angiogenesis in multiple myeloma, CLIN CANC R, 6(8), 2000, pp. 3111-3116
Effect of complete response on outcome following autologous stem cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Witzig, TE Lust, JA Larson, D Therneau, TM Kyle, RA Litzow, MR Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Effect of complete response on outcome following autologous stem cell transplantation for myeloma, BONE MAR TR, 26(9), 2000, pp. 979-983
Performance drivers: A practical guide to the balanced scorecard.
Authors: Lust, JA
Citation: Ja. Lust, Performance drivers: A practical guide to the balanced scorecard., PERS PSYCH, 53(2), 2000, pp. 506-509
Thalidomide in the treatment of relapsed multiple myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Kyle, RA Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Thalidomide in the treatment of relapsed multiple myeloma, MAYO CLIN P, 75(9), 2000, pp. 897-901
Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil
Authors: Kyle, RA Greipp, PR Gertz, MA Witzig, TE Lust, JA Lacy, MQ Therneau, TM
Citation: Ra. Kyle et al., Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil, BR J HAEM, 108(4), 2000, pp. 737-742
Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia
Authors: Go, RS Tefferi, A Li, CY Lust, JA Phyliky, RL
Citation: Rs. Go et al., Lymphoproliferative disease of granular T lymphocytes presenting as aplastic anemia, BLOOD, 96(10), 2000, pp. 3644-3646
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis
Authors: Gertz, MA Lacy, MQ Lust, JA Greipp, PR Witzig, TE Kyle, RA
Citation: Ma. Gertz et al., Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis, MED ONCOL, 16(2), 1999, pp. 104-109
The role of interleukin-1 beta in the pathogenesis of multiple myeloma
Authors: Lust, JA Donovan, KA
Citation: Ja. Lust et Ka. Donovan, The role of interleukin-1 beta in the pathogenesis of multiple myeloma, HEMAT ONCOL, 13(6), 1999, pp. 1117
Career movement of female employees holding lower-level positions: An analysis of the impact of the Type A behavior pattern
Authors: Stewart-Belle, S Lust, JA
Citation: S. Stewart-belle et Ja. Lust, Career movement of female employees holding lower-level positions: An analysis of the impact of the Type A behavior pattern, J BUS PSYCH, 14(1), 1999, pp. 187-197
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatmentof primary systemic amyloidosis
Authors: Gertz, MA Lacy, MQ Lust, JA Greipp, PR Witzig, TE Kyle, RA
Citation: Ma. Gertz et al., Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatmentof primary systemic amyloidosis, J CL ONCOL, 17(1), 1999, pp. 262-267
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis
Authors: Gertz, MA Lacy, MQ Lust, JA Greipp, PR Witzig, TE Kyle, RA
Citation: Ma. Gertz et al., Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis, AM J HEMAT, 61(2), 1999, pp. 115-119
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 497-503
Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma
Authors: Gertz, MA Lacy, MQ Inwards, DJ Chen, MG Pineda, AA Gastineau, DA Greipp, PR Lust, JA Tefferi, A Witzig, TE Kyle, RA Litzow, MR
Citation: Ma. Gertz et al., Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma, BONE MAR TR, 23(3), 1999, pp. 221-226
Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Autologous stem cell transplantation for relapsed and primary refractory myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Autologous stem cell transplantation for relapsed and primary refractory myeloma, BONE MAR TR, 23(12), 1999, pp. 1267-1272
Monoclonal gammopathies and associated skin disorders
Authors: Daoud, MS Lust, JA Kyle, RA Pittelkow, MR
Citation: Ms. Daoud et al., Monoclonal gammopathies and associated skin disorders, J AM ACAD D, 40(4), 1999, pp. 507-538
Role of cytokines in multiple myeloma
Authors: Anderson, KC Lust, JA
Citation: Kc. Anderson et Ja. Lust, Role of cytokines in multiple myeloma, SEM HEMATOL, 36(1), 1999, pp. 14-20
How to measure employee performance.
Authors: Lust, JA
Citation: Ja. Lust, How to measure employee performance., PERS PSYCH, 52(4), 1999, pp. 1089-1091
Recruiting employees: Individual and organizational perspectives.
Authors: Lust, JA
Citation: Ja. Lust, Recruiting employees: Individual and organizational perspectives., PERS PSYCH, 52(2), 1999, pp. 513-515
Scleromyxedema: A complete response to prednisone
Authors: Rayson, D Lust, JA Duncan, A Su, WPD
Citation: D. Rayson et al., Scleromyxedema: A complete response to prednisone, MAYO CLIN P, 74(5), 1999, pp. 481-484
Risultati: 1-25 | 26-27